/Passle/65b10a249576f7f0a5a2f163/MediaLibrary/Images/2024-11-13-11-57-03-771-6734940fd8026329178e8d63.png)
Companies in the life sciences sector and its sub-sectors, including pharmaceuticals, medical devices, diagnostics and services, are...
BioTalk
Powered by Bird & Bird
/Passle/65b10a249576f7f0a5a2f163/MediaLibrary/Images/2024-10-09-13-34-10-162-67068652a75ae96e1ecfeab1.png)
In recent decades, venture capital (VC) has played an increasingly important role in the high-risk and high-reward life sciences sector....
/Passle/65b10a249576f7f0a5a2f163/MediaLibrary/Images/2024-09-05-13-56-44-784-66d9b89c9c4fc63968366cbe.png)
On 18 July 2024 President Von der Leyen laid down the path for the next European Commission in her Political Guidelines for the next...
/Passle/MediaLibrary/Images/2024-07-30-14-32-46-741-66a8f98e926269fa77476cf4.jpg)
The UK life sciences industry takes centre-stage in two of the new Labour government’s “Five Missions For National Renewal”: economic...
/Passle/MediaLibrary/Images/2024-07-30-11-42-54-669-66a8d1be906525afd4dbcf24.jpg)
In May 2024, the Dutch government published the draft bill for the new Cybersecurity Act (Cyberbeveiligingswet – “CSA”) for consultation...
/Passle/65b10a249576f7f0a5a2f163/MediaLibrary/Images/2024-06-22-10-07-21-296-6676a2598e50ec2db9736d48.jpg)
On April 10, 2024, the European Parliament voted to adopt a revised version of the European Commission’s proposed reforms to...
/Passle/65b10a249576f7f0a5a2f163/MediaLibrary/Images/2024-06-22-10-00-16-005-6676a0b08e50ec2db9736a92.jpg)
On June 6, 2024, the Advocate General (AG) at the Court of Justice of the European Union (CJEU) delivered an opinion in case C-248/23...
/Passle/65b10a249576f7f0a5a2f163/MediaLibrary/Images/63d13afbf636e918380ad1f9/2024-02-19-16-51-24-046-65d3870ce4493541b7e46b63.jpg)
The SoHO proposal introduces the procedure for obtaining an authorisation for SoHO preparations by the introduction of an EU-wide...
/Passle/65b10a249576f7f0a5a2f163/MediaLibrary/Images/63d13afbf636e918380ad1f9/2024-02-13-18-33-34-638-65cbb5fea663ca0e2ecfcb90.jpg)
Back in May 2016, the scientific publication Nature surveyed over 1,500 researchers to find out how reproducible their work was. This...
/Passle/65b10a249576f7f0a5a2f163/MediaLibrary/Images/63d13afbf636e918380ad1f9/2024-02-13-18-36-43-285-65cbb6bb5560a271c18cf39d.jpg)
Telemedicine has been available to healthcare providers for several years. However, it was not until quite recently that the field of...
/Passle/65b10a249576f7f0a5a2f163/MediaLibrary/Images/63d13afbf636e918380ad1f9/2024-02-13-18-42-25-563-65cbb8117f09f56259d376ec.jpg)
The latest edition of the Legal 500: Pharmaceutical Advertising Comparative Guide is now online. The aim of this guide is to provide its...
/Passle/65b10a249576f7f0a5a2f163/MediaLibrary/Images/63d13afbf636e918380ad1f9/2024-02-13-18-46-51-107-65cbb91b5560a271c18cf8ab.jpg)
Approximately twenty years ago, the regulation of Substances of Human Origin (“SHO”) in Europe was reshaped by the introduction of the...
/Passle/65b10a249576f7f0a5a2f163/MediaLibrary/Images/63d13afbf636e918380ad1f9/2024-02-13-18-49-18-263-65cbb9aea663ca0e2ecfd3b1.jpg)
Apart from the Unified Patent Court Agreement and a large body of further treaties, regulations, directives and laws governing the...
/Passle/65b10a249576f7f0a5a2f163/MediaLibrary/Images/63d13afbf636e918380ad1f9/2024-02-13-18-51-43-008-65cbba3fa663ca0e2ecfd4f3.jpg)
Early this year it became clear that the long-pending reform of the European patent system is finally coming to fruition. With the...
/Passle/65b10a249576f7f0a5a2f163/MediaLibrary/Images/63d13afbf636e918380ad1f9/2024-02-13-18-57-33-266-65cbbb9d7f09f56259d37e89.jpg)
Start of the Provisional Application Phase and first committee meetings The Provisional Application Phase of the Unified Patent Court...
/Passle/65b10a249576f7f0a5a2f163/MediaLibrary/Images/63d13afbf636e918380ad1f9/2024-02-13-19-00-50-376-65cbbc625560a271c18cffa7.jpg)
Every year the Social Security Financing Law for 2022 (LFSS 2022) introduces several measures resulting in important changes for the life...